Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome.
about
Human growth hormone and glutamine for patients with short bowel syndromeGuidelines for management of patients with a short bowelThe effects of long-term total parenteral nutrition on gut mucosal immunity in children with short bowel syndrome: a systematic reviewEffect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study.[Example of safety measures for antineoplastic agents immediately after market launch--a case of TS-1 capsule all example use result investigation that executes safety monitoring--].Intestinal growth factors: potential use in the treatment of inflammatory bowel disease and their role in mucosal healing.Interactions between nutrients and peptide growth factors in intestinal growth, repair, and function.Impediments to the successful use of anabolic agents in clinical care.The management of patients with the short bowel syndromeIntestinal adaptation in short bowel syndrome.Systematic review: body composition in adults with inflammatory bowel disease.Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study.Reversal by growth hormone of homocysteine-induced epithelial-to-mesenchymal transition through membrane raft-redox signaling in podocytesIntestinal rehabilitation and the short bowel syndrome: part 2.Growth factors in inflammatory bowel disease: the actions and interactions of growth hormone and insulin-like growth factor-I.Criteria for the use of recombinant human growth hormone in short bowel syndrome.Intestinal mucosal atrophy and adaptationNew growth factor therapies aimed at improving intestinal adaptation in short bowel syndrome.Nutrient intake from habitual oral diet in patients with severe short bowel syndrome living in the southeastern United States.Growth hormone treatment for growth failure in pediatric patients with Crohn's disease.Pediatric intestinal failure: nutrition, pharmacologic, and surgical approaches.Growth factors: possible roles for clinical management of the short bowel syndrome.Complications of enterocutaneous fistulas and their management.Nutrition management of infants with surgical short bowel syndrome and intestinal failure.Intestinal adaptation following resection.Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.Growth hormone for intestinal adaptation in patients with short bowel syndrome: systematic review and meta-analysis of randomized controlled trialsThe pharmacologic treatment of short bowel syndrome: new tricks and novel agents.The effect of recombinant human growth hormone (rhGH) on trinitrobenzene sulfonic acid-induced colitis in rats: an experimental study.Effect of recombinant human growth hormone on intestinal absorption and body composition in children with short bowel syndrome.Reconnection surgery in adult post-operative short bowel syndrome < 100 cm: is colonic continuity sufficient to achieve enteral autonomy without autologous gastrointestinal reconstruction? Report from a single center and systematic review of literat
P2860
Q24234876-2070EC6E-A6F4-442F-B1C8-525151C99639Q24646515-656E4154-EE5A-46B6-BA30-E10AF7A18EEAQ24793103-98E5973A-3E2A-44C2-A194-B8082EBDA59FQ32059651-1F1666F7-0BF4-4156-89E3-8600D561EB1AQ33369915-9A206677-F4F7-4520-B73D-7AD46C70AF49Q33694525-544663C0-B3FD-44F7-B6DC-DEBB09760B5FQ33778733-18D59AA8-9D79-4625-994D-CFA594994C06Q33778758-199C88CB-B7A3-41DB-AF5D-CBC87CDF6138Q34521154-54A48C6F-3395-4D35-84DB-59C6BFF9ABFAQ34692621-E300B4E6-6099-4C09-9B5A-3D07E633F382Q34771160-F0AED819-5DAA-4D8B-A7DD-9ACF7A63B586Q35360775-BFB4C6FB-0C43-4195-9C97-B50EDF6088BFQ35564803-F939C5E0-8D04-4978-8C2A-A927A82B5784Q35872056-0472DB64-B927-4E2F-9924-87D71556EB7BQ35997118-5DAC1242-C8E5-4C36-88AA-2695BF65599BQ36278446-9DFE68CA-5FFF-4EBD-AF02-DFA30ED2415FQ36429803-AD803CC7-6C43-4BCA-B0F8-A5DAEB550E66Q36489336-7ECC71D3-7FE1-4128-B427-A5BA16656461Q36740253-68F15963-A584-4587-8FA3-7557C6891ED4Q36989883-003068E1-0D94-479E-B2DA-B64FA8D1AE65Q37016607-3D5350CB-D9E4-4CCF-BDAD-0A11EB6430EFQ37685500-9AB240EB-CBE6-4979-8B6D-ABAB730FA1C5Q37925493-4A0935AD-5064-4770-8F87-E04191665010Q38114043-466D5310-1D94-4139-9CE8-AB4F149DEDBFQ38192586-25A34702-4F1E-4E51-8FB0-53AA21C0F9B4Q38194971-65BB4783-D4DD-42B4-8C7F-D29FB1A6136AQ38197594-18DF2EAA-E71D-443D-9721-EC80CC65EB3DQ38232874-2AE12354-B557-4352-8EC4-FA1DD919D855Q44914875-B4F194E2-EB30-45BD-9558-4464958C251DQ45575173-2E4B4A07-8BE2-4CC4-86CE-458F48BA36D2Q47143016-50108A7D-F3AB-4E1E-9F86-C03AEF2FC5CD
P2860
Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Low-dose recombinant human gro ...... nts with short bowel syndrome.
@en
type
label
Low-dose recombinant human gro ...... nts with short bowel syndrome.
@en
prefLabel
Low-dose recombinant human gro ...... nts with short bowel syndrome.
@en
P2093
P1433
P1476
Low-dose recombinant human gro ...... ents with short bowel syndrome
@en
P2093
B A Bengtsson
S Nordgren
P356
10.1097/00000658-199701000-00010
P407
P50
P577
1997-01-01T00:00:00Z